Clinical Trial Results:
Bortezomib-Doxorubicin-Dexamethasone (BDD) as Treatment for Patients with Multiple Myeloma Presenting with Acute Renal Failure
Summary
|
|
EudraCT number |
2005-003001-85 |
Trial protocol |
AT CZ HU SK |
Global completion date |
30 Nov 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
02 Jan 2020
|
First version publication date |
02 Jan 2020
|
Other versions |
|
Summary report(s) |
Ludwig et al_BDD renal failure MM_JCO 2010 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.